Company: LENZ
Filing Date: 2025-04-15
Form Type: 8-K
Source: 0001815776-25-000025
Chunk: 2

Company: LENZ Therapeutics, Inc.
Filing Date: 2025-04-15
Form: 8-K
Item: Item 8.01
Chunk 2
---
Item 8.01 Other Events.

The information set forth above in Item 2.02 is incorporated by reference herein.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  LENZ THERAPEUTICS, INC.                                                                
  Dated: April 15, 2025                                                                  
                               By:         /s/ Daniel Chevallard                         
                               Name:       Daniel Chevallard                             
                               Title:      Chief Financial Officer                       
                                           (Principal Financial and Accounting Officer)